Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLC /von 2006-02-01 / Clin. Cancer Res. 2006 Feb;12(3 Pt 1):878-87Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines
/in International Publications, Ovarian Cancer /von 2006-02-01 / Cancer Gene Ther. 2006 Feb;13(2):182-93Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2006-02-01 / Clin Cancer Res 2006 Feb;12(3 Pt 1):869-77Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo
/in Colorectal Cancer, International Publications /von 2006-01-21 / World J. Gastroenterol. 2006 Jan;12(3):473-8Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70
/in Chronic Virus Hepatitis, International Publications /von 2006-01-18 / Vaccine 2006 Feb;24(7):887-96Immunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens
/in Dendritic Cells, International Publications /von 2006-01-18 / Immunobiology 2006;211(1-2):29-36Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
/in International Publications, Malignant Melanoma /von 2006-01-17 / Ann. Oncol. 2006 Apr;17(4):563-70Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection
/in HIV/AIDS, International Publications /von 2006-01-09 / Proc. Natl. Acad. Sci. U.S.A. 2006 Jan;103(3):738-43Dendritic cell defects in patients with cancer: mechanisms and significance
/in Dendritic Cells, International Publications /von 2006-01-05 / Breast Cancer Res. 2006;8(1):101
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de